Eligibility Criteria

Inclusion and exclusion criteria
Descripción

Inclusion and exclusion criteria

To assess the ability to recapitulate known results, whole genome sequencing was performed retrospectively on two infants with molecular diagnoses that had previously been identified by clinical testing. These samples (UDXXXX) were selected from a validation set of 384 samples with known molecular diagnoses for one or more genetic diseases.
Descripción

To assess the ability to recapitulate known results, whole genome sequencing was performed retrospectively on two infants with molecular diagnoses that had previously been identified by clinical testing. These samples (UDXXXX) were selected from a validation set of 384 samples with known molecular diagnoses for one or more genetic diseases.

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C4744597
UMLS CUI [1,2]
C1516048
UMLS CUI [1,3]
C3640076
UMLS CUI [1,4]
C1514923
UMLS CUI [1,5]
C0021270
UMLS CUI [1,6]
C1513388
UMLS CUI [1,7]
C5236074
UMLS CUI [1,8]
C1516634
UMLS CUI [2,1]
C1519941
UMLS CUI [2,2]
C0150098
UMLS CUI [2,3]
C1513388
UMLS CUI [2,4]
C0019247
To assess the potential diagnostic use of WGS, sequencing was prospectively performed on four undiagnosed newborns with clinical presentations that strongly suggested a genetic disorder as well as one affected sibling and their unaffected parents. Seven prospective samples were selected from families with probands that presented in infancy, among 143 individuals without molecular diagnoses who were enrolled between November 2011 and April 2012 for exome or genome sequencing.
Descripción

To assess the potential diagnostic use of WGS, sequencing was prospectively performed on four undiagnosed newborns with clinical presentations that strongly suggested a genetic disorder as well as one affected sibling and their unaffected parents. Seven prospective samples were selected from families with probands that presented in infancy, among 143 individuals without molecular diagnoses who were enrolled between November 2011 and April 2012 for exome or genome sequencing.

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1516048
UMLS CUI [1,2]
C3245505
UMLS CUI [1,3]
C0430022
UMLS CUI [1,4]
C3640076
UMLS CUI [1,5]
C0033522
UMLS CUI [1,6]
C0021289
UMLS CUI [1,7]
C2708283
UMLS CUI [1,8]
C0019247
UMLS CUI [1,9]
C0037047
UMLS CUI [1,10]
C0392760
UMLS CUI [1,11]
C2986417
UMLS CUI [1,12]
C0030551
UMLS CUI [2,1]
C0021289
UMLS CUI [2,2]
C0332288
UMLS CUI [2,3]
C1513388
UMLS CUI [2,4]
C3640077
UMLS CUI [2,5]
C3640076

Similar models

Eligibility Criteria

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Inclusion and exclusion criteria
To assess the ability to recapitulate known results, whole genome sequencing was performed retrospectively on two infants with molecular diagnoses that had previously been identified by clinical testing. These samples (UDXXXX) were selected from a validation set of 384 samples with known molecular diagnoses for one or more genetic diseases.
Item
To assess the ability to recapitulate known results, whole genome sequencing was performed retrospectively on two infants with molecular diagnoses that had previously been identified by clinical testing. These samples (UDXXXX) were selected from a validation set of 384 samples with known molecular diagnoses for one or more genetic diseases.
boolean
C4744597 (UMLS CUI [1,1])
C1516048 (UMLS CUI [1,2])
C3640076 (UMLS CUI [1,3])
C1514923 (UMLS CUI [1,4])
C0021270 (UMLS CUI [1,5])
C1513388 (UMLS CUI [1,6])
C5236074 (UMLS CUI [1,7])
C1516634 (UMLS CUI [1,8])
C1519941 (UMLS CUI [2,1])
C0150098 (UMLS CUI [2,2])
C1513388 (UMLS CUI [2,3])
C0019247 (UMLS CUI [2,4])
To assess the potential diagnostic use of WGS, sequencing was prospectively performed on four undiagnosed newborns with clinical presentations that strongly suggested a genetic disorder as well as one affected sibling and their unaffected parents. Seven prospective samples were selected from families with probands that presented in infancy, among 143 individuals without molecular diagnoses who were enrolled between November 2011 and April 2012 for exome or genome sequencing.
Item
To assess the potential diagnostic use of WGS, sequencing was prospectively performed on four undiagnosed newborns with clinical presentations that strongly suggested a genetic disorder as well as one affected sibling and their unaffected parents. Seven prospective samples were selected from families with probands that presented in infancy, among 143 individuals without molecular diagnoses who were enrolled between November 2011 and April 2012 for exome or genome sequencing.
boolean
C1516048 (UMLS CUI [1,1])
C3245505 (UMLS CUI [1,2])
C0430022 (UMLS CUI [1,3])
C3640076 (UMLS CUI [1,4])
C0033522 (UMLS CUI [1,5])
C0021289 (UMLS CUI [1,6])
C2708283 (UMLS CUI [1,7])
C0019247 (UMLS CUI [1,8])
C0037047 (UMLS CUI [1,9])
C0392760 (UMLS CUI [1,10])
C2986417 (UMLS CUI [1,11])
C0030551 (UMLS CUI [1,12])
C0021289 (UMLS CUI [2,1])
C0332288 (UMLS CUI [2,2])
C1513388 (UMLS CUI [2,3])
C3640077 (UMLS CUI [2,4])
C3640076 (UMLS CUI [2,5])